SOCRA CCRP EXAM 2023-2024 ACTUAL EXAM 200 QUESTIONS AND CORRECT DETAILED ANSWERS WITH RATIONALES |AGRADE

SOCRA CCRP EXAM 2023-2024 ACTUAL EXAM 200
QUESTIONS AND CORRECT DETAILED ANSWERS WITH
RATIONALES |AGRADE
When is a short form ICF needed? – ANSWER- For subjects whose first
language is not English
What are the 10 points of the Nuremberg Code? – ANSWER- – Required
voluntary, informed consent

  • Experiment aims at positive results for society
  • Based on previous knowledge that justifies the experiment
  • Study design avoids unnecessary physical and mental suffering and
    injuries
  • Not conducted if there is any reason to believe it implies a risk of death
    or disabling injury
  • Risks < Benefits
  • Preparations and facilities must be provided to protect subjects against
    risks
  • Staff must be fully trained and qualified
  • Subject must be free to quit at any time
  • Medical staff stop the experiment at any time if they observe
    continuation would be dangerous.
    When can an investigational product be used without a signed consent? –
    ANSWER- – in a life threatening situation
  • inability to communicate
  • time is not sufficient
  • no alternate approved method available that provides an equal or
    greater likelihood of saving the subject’s life
    When can wards participate in a study? – ANSWER- – research related
    to ward status
  • conducted in an environment with majority of children are not wards
  • advocate has best interest of child during research
  • advocate must not be associated with guardian organization, clinical
    investigation, or the investigator
    How long must a Suspected Unexpected Serious Adverse Reaction
    (SUSAR) be reported to the IRB? – ANSWER- $50,000

What is considered a significant payment made from the sponsor to the
investigator? – ANSWER- > $25,000
What is the main purpose of the IRB? – ANSWER- Assure protection of
rights, safety, and welfare of human subjects.
Who provides the final approval of a study?
a. Sponsor
b. FDA
c. IRB – ANSWER- c. IRB
IRB must find when approving a study: – ANSWER- – risks are
minimized

  • risks are reasonable for the anticipated benefits
  • selection of subjects is equitable
  • ICF follows guidelines
  • ICF documented appropriately
  • Adequate provisions for monitoring data collected to ensure the safety
    of subjects
  • privacy and confidentiality is protected
  • additional safeguards in place to protect vulnerable populations
  • copies of research proposals reviewed
  • minutes of IRB meetings
  • records of continuing reviews
  • copies of correspondence between IRB and investigator
  • list of IRB members
  • written procedures for the IRB
  • statement of significant findings provided to subjects – ANSWERWhat is documented at IRB meetings?
    What are significant risk devices? – ANSWER- – implants with potential
    serious risks
  • used to support or sustain human life
  • substantial importance in diagnosing, curing, or treating disease
    What kind of investigational devices are exempt from Premarket
    approval requirements? (IDE) – ANSWER- – diagnostic devices that are
    non-invasive
  • for vet or lab use
  • custom device not intended for commercial distribution
  • distrubuted prior to May 1976
    Who must be part of the IRB members? – ANSWER- – males and
    females
  • varied background
  • at least 5 members
  • 1 scientific background

Leave a Comment

Scroll to Top